期刊论文详细信息
BMC Complementary and Alternative Medicine
Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang
Hyeun-Kyoo Shin2  Jung-Hoon Kim1  Ohn Soon Kim2  Chang-Seob Seo2 
[1] Division of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam 626-870, Republic of Korea;Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, 1672 Yuseong-daero Yuseong-gu, Daejeon 305-811, South Korea
关键词: Traditional Korean medicine;    HPLC–PDA;    Antiatherosclerosis effect;    Hwangryunhaedok-tang;    Simultaneous quantification;   
Others  :  1172055
DOI  :  10.1186/s12906-015-0632-5
 received in 2014-07-15, accepted in 2015-03-24,  发布年份 2015
PDF
【 摘 要 】

Background

Hwangryunhaedok-tang (HHT) is a traditional herbal medicine that is used for the treatment of fever, inflammation, gastritis, and hypertension. In this study, we performed simultaneous determination of the five components, geniposide (1), baicalin (2), coptisine (3), palmatine (4), and berberine (5) in HHT by using a high-performance liquid chromatography–photodiode array (HPLC–PDA) analysis. We also evaluated the antioxidative activity of HHT and compounds 15 by measuring their effects on low-density lipoprotein (LDL) oxidation and antiproliferative abilities in vascular smooth muscle cells (VSMCs).

Methods

Five compounds were separated within 40 min by using a Gemini C18 column (temp. 35°C; two-component gradient elution; flow rate 1.0 mL/min; detector 240 and 277 nm). The activities of HHT and compounds 15 were tested with the radical scavengers 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt and 2,2-diphenyl-1-picrylhydrazyl, in thiobarbituric acid reactive substance assays, and in relative electrophoretic mobility assays using CuSO4-induced LDL oxidation systems. The antiproliferative effects of samples on platelet-derived growth factor (PDGF)-induced VSMC proliferation were studied by using a cell proliferation assay.

Results

Regression analysis of the five major compounds showed good linearity (r2 ≥ 0.9997) in different concentration ranges. The recoveries of the five compounds were in the range 86.31–110.78%, with relative standard deviations below 2.1%; those of intra- and interday precision were 0.04–3.78% and 0.04–1.69%, respectively. HHT reduced the oxidation properties of LDL induced by CuSO4 and inhibited cell proliferation in PDGF-treated VSMCs. Among the five components, compound 2 could effectively suppress LDL oxidation and PDGF-induced VSMC proliferation.

Conclusions

The established HPLC–PDA method will help to improve quality control of HHT. The results demonstrate that HHT has antiatherosclerotic activity and that it functions by modulating LDL oxidation and VSMC proliferation. The effects of HHT may be attributed, at least I part, to compound 2.

【 授权许可】

   
2015 Seo et al.; licensee BioMed Central.

【 预 览 】
附件列表
Files Size Format View
20150421012013875.pdf 1222KB PDF download
Figure 5. 39KB Image download
Figure 4. 41KB Image download
Figure 3. 28KB Image download
Figure 2. 31KB Image download
Figure 1. 25KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Normile D. Asian medicine: the new face of traditional Chinese medicine. Science. 2003; 299:188-190.
  • [2]Xue T, Roy R. Studying traditional Chinese medicine. Science. 2003; 300:740-741.
  • [3]Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci. 2005; 26:558-563.
  • [4]Liu S, Yi LZ, Liang YZ. Traditional Chinese medicine and separation science. J Sep Sci. 2008; 31:2113-2137.
  • [5]Hur J. Donguibogam. Namsandang, Seoul; 2007.
  • [6]Lu J, Wang JS, Kong LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol. 2011; 134:911-918.
  • [7]Yue R, Zhao L, Hu Y, Jiang P, Wang S, Xiang L et al.. Rapid-resolution liquid chromatography TOF-MS for urine metabolomics analysis of collagen-induced arthritis in rat and its applications. J Ethnopharmacol. 2013; 145:465-475.
  • [8]Ohta Y, Kobayashi T, Nishida K, Sasaki E, Ishiguro I. Preventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in rats. J Ethnopharmacol. 1999; 67:377-384.
  • [9]Yu YL, Lu SS, Yu S, Liu YC, Wang P, Xie L et al.. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats. J Ethnopharmacol. 2009; 124:444-449.
  • [10]Zhang Q, Ye YL, Yan YX, Zhang WP, Chu LS, Wei EQ et al.. Protective effects of Huanglian-Jie-Du-Tang on chronic brain injury after focal cerebral ischemia in mice. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009; 38:75-80.
  • [11]Xu J, Murakami Y, Matsumoto K, Tohda M, Watanabe H, Zhang S et al.. Protective effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) against impairment of learning and memory induced by transient cerebral ischemia in mice. J Ethnopharmacol. 2000; 73:405-413.
  • [12]Hwang YS, Shin CY, Huh Y, Ryu JH. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci. 2002; 71:2105-2117.
  • [13]Ohta Y, Kongo-Nishimura M, Hayashi T, Kishikawa T. Effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. J Ethnopharmacol. 2004; 94:323-329.
  • [14]Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT et al.. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J Gastroenterol Hepatol. 2008; 23:290-299.
  • [15]Sekiya N, Kainuma M, Hikiami H, Nakagawa T, Kouta K, Shibahara N et al.. Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits. Biol Pharm Bull. 2005; 28:294-298.
  • [16]Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362:801-809.
  • [17]Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138:S419-420.
  • [18]Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med. 1999; 26:1231-1237.
  • [19]Moreno MI, Isla MI, Sampietro AR, Vattuone MA. Comparison of the free radical-scavenging activity of propolis from several regions of Argentina. J Ethnophamacol. 2000; 71:109-114.
  • [20]Barnhart RL, Busch SJ, Jackson RL. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. J Lipid Res. 1989; 30:1703-1710.
  • [21]Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52:302-310.
  • [22]Sparks DL, Phillips MC. Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis. J Lipid Res. 1992; 33:123-130.
  • [23]Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990; 9:515-540.
  文献评价指标  
  下载次数:68次 浏览次数:29次